ArticleJournal of cancer research and clinical oncology2014

Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies.

Danielle C Chinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.